Antithrombin III assay using thrombin in disseminated intravascular coagulation (DIC), other thromboembolic disorders and hepatic diseases

Indian Journal of Pathology and Microbiology

Volumn 47, Issue 2, 2004, Pages 210-212

  Saxena, V ^a   Mishra, D K ^a,b   Subramanya, H ^a   Satyanarayana, S ^a   Sharma, A ^a  

^a ARMED FORCES MEDICAL COLLEGE   (India)

^b Department of Physiology Pune   (India)

Author keywords

Antithrombin III; Clotting assay; Disseminated intravascular coagulation; Thrombin

Indexed keywords

ANTITHROMBIN III; CHROMOGENIC SUBSTRATE; THROMBIN;

ADULT; ARTICLE; ASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; HUMAN; LIVER DISEASE; MALE; THROMBOEMBOLISM; VEIN THROMBOSIS;

ADULT; ANTITHROMBIN III; BLOOD CHEMICAL ANALYSIS; CASE-CONTROL STUDIES; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; THROMBIN; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 27844444304     PISSN: 03774929     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. th ed. Philadelphia: Williams & Wilkins, 1999:684-764.
2. th ed. Oxford: Butterworth-Hienemann, 1999: 550-80.
3. Rosenberg RD, Damus PS. The purification and mechanism of action of human antithrombin-heparin cofactor. J Biol Chem 1973; 248:6490-505.
4. Bick RL. Disseminated intravascular coagulation: a clinical/laboratory study of 48 patients. Ann NY Acad Sci 1981; 370:843-50.
5. Matsuo T, Matsuo C, Matsuo O. Characterization of the biological activity of antithrombin III in patients with hepatic cirrhosis. Clin Chem Acta 1984; 140(2):125-32.
6. Cosgriff TM, Bishop DT, Hershgold EJ et al. Familial antithrombin III deficiency: its natural history, genetics, diagnosis and treatment. Medicine 1983; 62:209-20.
7. th ed. New York: Mc Graw-Hill, 1995:101-2.
8. Laffain MA, Bradshaw AE. Investigation of a thrombotic tendency. In: Dacie JV, Lewis SM, eds. Practical haematology. 8th ed. Edinburg: Churchill Livingstone, 1995:361-2.
9. Von Kaulla E, Von Kaulla KN. Antithrombin III and diseases. Am J Clin Pathol 1967; 48:69-80.
10. Howie PW, Prentic CRM, MeNicol GP. A method of antithrombin estimation using plasma defibrinated with Ancrod. Br J Haematol 1973; 25:101-10.
11. Biggs R, Denson KWE, Akman N, Borret R, Hadden M. Antithrombin III, antifactor Xa and heparin. Br J Haematol 1970; 19:283-305.
12. Odegard OR, Abildgaard U. Antithrombin III: Critical review of assay methods. Significance of variations in health and disease. Haemostasis 1978; 7:127-32.
13. Chan V, Chan TK, Wong V, Tso SC, Todd D. The determination of antithrombin III by radioimmunoassay and its clinical appication. Br J Haematol 1979; 41(4):563-72.
14. Napoli VM, Krzyzaniak R, Vroon DH, Newton JL. Fluorometric assays of antitrombin III. Diagnostic value in 112 patients with abnormal hemostasis. Am J Clin Pathol 1985; 84(2):173-9.
15. Rodzynek JJR, Preux C, Leautaud P, Abramovici J, Paolo AD, Deleourt AA. Diagnostic value of antithrombin III and aminopyrine breath test in liver disease. Arch Intern Med 1986; 146:677-80.
16. Kay JH, Hutton SB, Weiss GM, Ochsner A. Studies on an antithrombin III. Surgery 1950; 28:24-8.
17. Von Kaulla E, Von Kaulla KN. Deficiency of antithrombin III activity associated with hereditary thrombosis tendency. J Med 1972; 3:349-58.